SD 169

Based on 20 reference(s) in Google Scholar 80 100 20

Axon 1357

CAS [1670-87-7]

MF C9H8N2O
MW 160.17

  • Purity: 99%
  • Soluble in DMSO and Ethanol

SD 169

Description

ATP-competitive, orally active inhibitor of p38α MAP kinase (IC50 = 3.2 nM); being 38 fold selective vs against p38β MAP kinase (IC50 = 122 nM) and no inhibitory activity against a panel of other kinases including p38γ MAP kinase, ERK2, JNK-1 and MAPKAPK-2.

KEYWORDS: SD 169 | supplier | p38α MAPK inhibitor | SD169 | SD-169 | CAS [1670-87-7] | MAPK | p38-alpha | ATP-competitive | orally active | MAP kinase | ERK2 | JNK1 | MAPKAPK2

Order
Size Unit Price Stock
5 mg €60.00 In Stock
25 mg €180.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €90.00 In Stock
2 x 25 mg €260.00 In Stock
Need more? Bulk Inquiry

Recently Viewed

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...